Past Bulletins and News Flashes - 2003
News
Flash, September 23, 2003
NIH Notice About Grant Application Submission Delays Due To Hurricane
Isabel
Below from the NIH Guide for Grants and Contracts
Release Date: September 22, 2003
Notice: NOT-OD-03-064
Hurricane Isabel has led to the closure of institutions on the East
Coast and the Federal government in the Washington, D.C. area. The NIH
realizes that this may cause problems for investigators who are planning
on submitting grant applications. Applications that are submitted late
because of problems caused by Hurricane Isabel should include a cover
letter noting the reasons for the delay. It is not necessary to get permission
in advance for hurricane-related delays in grant application submission.
It is expected that the delay will generally not exceed the time period
that an institution is closed.
Update from Edward Trapido, Sc.D.
Associate Director, Epidemiology and Genetics Research
Program (EGRP)
This is a brief message to let you know that we'll be at the annual
meeting of the American College of Epidemiology (ACE) in Chicago, Sept.
7-9, and to tell you some recent news about our grantees and activities
of the Epidemiology and Genetics Research Program (EGRP). (more...)
News
Flash, July 7, 2003
Croyle Named Head of NCI Division of Cancer Control and Population Sciences
The
National Cancer Institute (NCI) has announced the appointment of Robert
T. Croyle, Ph.D., as director of its Division of Cancer Control and Population
Sciences (DCCPS). Croyle has been the acting division director since November
2002, and is the division's former associate director for behavioral research.
Croyle brings to the position a wealth of experience in cancer control
research, including work ranging from prevention to survivorship. He has
been an advocate for and collaborator on many cross-cutting issues such
as transdisciplinary science, genetic testing, genetic epidemiology, health
promotion, measurement, and dissemination. Croyle is responsible for building
DCCPS' highly regarded Behavioral Research Program, where he spent four
years contributing to some of NCI's highest priority areas.
The division's major initiatives include cancer communications, health
disparities, quality of care, genes and the environment, treatment outcomes
and quality of life for cancer survivors, and tobacco control - important
areas of investment that span the continuum of discovery, development,
and delivery. In his leadership role, Croyle is responsible for 170 employees
(excluding interns, fellows, and federal contractors), almost 800 extramural
grants valued at over $365 million, over $22 million in contracts, and
an additional $75 million in operating budgets for programs and branches.
"I am thrilled to have the opportunity to continue my work with
the division [of Cancer Control and Population Sciences]," said Croyle.
"I couldn't ask for more hard-working, intelligent, and creative
colleagues than the ones I've had the pleasure of working with over the
past five years. DCCPS is on the cutting edge of research in epidemiology
and genetics, behavior, health services, surveillance, and survivorship.
It's an exciting place to be."
Before joining NCI in 1998, Croyle worked at three academic institutions
and two cancer centers. He spent nine years as a professor of psychology,
member of the Huntsman Cancer Institute, and member of the Genetic Science
in Society Program at the University of Utah in Salt Lake City. Prior
to that, he was a visiting investigator at the Fred Hutchinson Cancer
Research Center in Seattle, visiting assistant professor of psychology
at the University of Washington, and assistant professor of psychology
at Williams College in Massachusetts.
"I am very pleased that Dr. Croyle has accepted the position. He
brings leadership experience and expertise in the many facets of cancer
control research. He is an energetic leader and a person who will further
NCI's high standards for research, collaboration, and outreach,"
said NCI Director Andrew von Eschenbach, M.D.
Croyle received his Ph.D. in social psychology from Princeton University
in 1985, and graduated Phi Beta Kappa with a B.A. in psychology from the
University of Washington in 1978. His recent research has examined how
individuals process, evaluate, and respond to disease risk information,
including medical diagnoses, risk factor screening, and tests for BRCA1
and BRCA2 mutations. His research has been published in professional journals
in behavioral science, public health, and cancer, and he has edited two
volumes, Mental Representation in Health and Illness (1991) and Psychosocial
Effects of Screening for Disease Prevention and Detection (1995).
He is a member of the Academy of Behavioral Medicine Research and a fellow
of the Society of Behavioral Medicine. His service on journal editorial
boards includes positions as an associate editor for Cancer Epidemiology,
Biomarkers and Prevention, and a consulting editor for Health Psychology
and the British Journal of Health Psychology.
This Epidemiology and Genetics Research Program (EGRP) Bulletin provides
information about research funding, research resources, and policies and
procedures important for grantees and grant applicants who may be supported
through its Program. Our aim is to help you successfully navigate the
grant application process and to support your research efforts. EGRP manages
a comprehensive program of grant-supported, population-based research
to increase our understanding of cancer etiology and prevention.
- Funding Opportunities
- NCI Articulates Future Plans
- Comprehensive Cancer Data on Women of Color Published
- Research Resources Provided by EGRP
- Cancer Family Registries for Breast/Ovarian and
Colon Cancer
- Cancer Genetics Network
- Geographic Information System for Breast Cancer
and Other Research
- Need Help Identifying Sources of Human Specimens and
Data?
- Final Statement on Sharing Research Data Published
- New Practice on Resubmission of Certain Applications
- Other Support Information Must Be Provided
Before an Award Can Be Made
- Advance Notice Required To Submit Large Budget Applications
- Increased Support for Competing Continuations Capped
- Impact of HIPAA Privacy Rule on NIH Grantees Explained
- Sources of Information on Grant Policies, Funding,
Training
- EGRP Staff
News
Flash, March 5, 2003
NCI's Latest Planning and Budget Document Now Available
The National Cancer Institutes (NCI) planning and budget proposal
for Fiscal Year 2004, The Nation's Investment in Cancer Research, is now
available on-line or in print. This document communicates NCIs vision
and plans for the future and is a guide for operational planning and priority
setting. In releasing the report, NCI Director Andrew C. von Eschenbach,
M.D., said the document is built around the discovery-development-delivery
continuum, and a framework that emphasizes capacity building, accelerating
discovery and its application, and addressing areas of public health emphasis.
The
Epidemiology and Genetics Research Program (EGRP) recommends reading the
document and encourages you to consider it in planning your research.
In grant applications, we suggest referring to relevant sections or passages,
when appropriate, and indicating how the proposed research contributes
to NCIs plans.
Of particular interest to investigators in cancer epidemiology may be
the sections on:
- Genes and the environment, an area identified as an Extraordinary
Opportunity for Investment where focused research can produce dramatic
progress toward reducing the burden of cancer. The goal is to discover
genetic, environmental, and lifestyle factors and their interactions
that define cancer risk and inform strategies for cancer control.
- Reducing cancer-related health disparities. The goal is to understand
the fundamental causes of health disparities in cancer, develop effective
interventions to reduce these disparities, and facilitate their implementation.
- Research on tobacco and tobacco-related cancers. The goal is to understand
the causes of tobacco use, addiction, and tobacco-related cancers and
apply this knowledge to their prevention and treatment.
Special sections of the document also point to crosscutting themes for
disease-specific research and research directed toward a better understanding
of the interface of aging and cancer. New priority areas focus attention
on the tumor microenvironment and on cancer survivorship. New objectives
emphasize studies of cancer and the immune system, molecular biosensors,
nanotechnology, palliative care, and symptom management.
Access the document on-line, or
order a print copy from NCIs On-line
Publications Locator Service.
News
Flash, February 20, 2003
Delays in Grant Application Submissions, Practices Changed for Resubmission
of Certain Applications
- Delays in Grant Application Submissions
The recent winter storms have led to closures of institutions and
the Federal Government. The NIH realizes that this may cause problems
for investigators who are submitting grant applications for special
receipt dates (RFAs and PARs) for the week of February 17, 2003. Applications
for special receipt dates that are submitted late because of the recent
storms should include a cover letter noting the reasons for the delay.
It is not necessary to get permission in advance for weather-related
delays in grant application submission; please do not call the Division
of Receipt and Referral to request such permission.
It is important that these applications be received by NIH no later
than February 26 so that they can be identified before the arrival
of the March 1 unsolicited applications. Because March 1 falls on
a Saturday, applications will be on time if they are sent by Monday,
March 3, 2003. The critical date is the submission date, not the arrival
date. If the recent storms or other extraordinary circumstances lead
to a delay in submission for March 3, please include a cover letter
explaining the reasons for the delay; again, please do not call to
request permission to be late.
The above notice, NOT-OD-03-030,
appeared in the NIH Guide for Grants and Contracts; release
date: February 19, 2003.
- NIH Changes Practice for Resubmission of Unpaid RFAs and Applications
with Changed Grant Activity Mechanism
NIH is changing its practice regarding resubmission of unpaid applications
received in response to Request for Applications (RFA) and applications
with changed grant activity mechanisms. The change affects three categories
of applications:
- Applications that were originally submitted in response to an
RFA and then resubmitted as an investigator-initiated application.
- Applications that were originally submitted as investigator-initiated
applications and subsequently resubmitted in response to an RFA.
- Applications that were originally submitted using one grant mechanism
and subsequently resubmitted using a different grant mechanism (for
example, an application that was originally an R01 and then is resubmitted
as an R21).
This change was announced in a Notice in the NIH Guide. The
Notice explains that since an RFA often has special considerations
of eligibility, scientific scope, and review criteria, it is felt
that most unfunded applications should be resubmitted as NEW applications.
Submission of a new application will allow the applicant to fully
benefit from the NIH policy that allows an applicant to submit two
revisions within two years. Also, applicants can benefit from considering
comments made in summary statements in the preparation of their new
application.
Full details appear in the Notice, NOT-OD-O3-019;
release date: January 16, 2003.
|